Document is current
Any future updates will be listed below
-
Authors
Etima, Juliane http://orcid.org/0000-0002-5879-6000
Katz, Ariana W. K.
Duby, Zoe
Garcia, Morgan
Palanee-Phillips, Thesla
Reddy, Krishnaveni
Mathebula, Florence
Zimba, Chifundo
Mansoor, Leila E.
Singh, Devika
Manengamambo, Elmah
Naidoo, Sarita
Soto-Torres, Lydia
Montgomery, Elizabeth T.
,
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068633, UM1AI068615, UM1AI106707)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (UM1AI068633, UM1AI068615, UM1AI106707)
- License Information
-
More Information
Article History
Accepted: 15 October 2021
First Online: 2 November 2021
Declarations
:
: The primary author implemented the study at the Kampala-Uganda site as the Investigator of Record through the Microbicide Trials Network (MTN). The study was funded by the National Institute of Allergy and Infectious Diseases through individual grants (UM1AI068633, UM1AI068615 and UM1AI106707), with co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health, all components of the U.S. National Institutes of Health (NIH). The primary author received salary support during the implementation of this study.
: This study was approved at the various study sites by all regulatory/ethics committees in each respective country. At Makerere University-Johns Hopkins University (MUJHU) in Uganda where the primary author conducted the study, ethical approval was received from Joint Clinical Research (JCRC) ethics review committee, Uganda National Council for Science and Technology (UNCST) and Johns Hopkins Medicine IRB. All study participants were consented for participation in the study, dissemination and publication of the study findings.
